despite caps tandem yearly spider result signifies morbid mortal aren option treat influenza virus ia infect remain limit challenge vaccine prefer intervene strategy efficacy reduce elderly infant suspect sever ndor fatal admit antigen variant complex product efficacy vaccine similarly effect current use antivirus drug leopard develop resist like mani virus reliant host factor signalingpathway replica could potent offer alter hostfactor long recon attract therapeutic candid recent target antivirus future strategy combat like include approach alter hostviru interact one hand damper harm immune response use biology response modify brm principal biology active agent include antibody small peptide molecule influence already clinic align autoimmune disease repurposed would allow accuser review address potent differ brm class model induce 